Ozempic maker’s new weight-loss drug works better, but not quite good enough for analysts

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
Article Attribution | Read More at Article Source
The post Ozempic maker’s new weight-loss drug works better, but not quite good enough for analysts appeared first on RocketNews.